Literature DB >> 27402921

Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

David J Taber1, Kelly J Hunt2, Cory E Fominaya2, Elizabeth H Payne2, Mulugeta Gebregziabher2, Titte R Srinivas2, Prabhakar K Baliga2, Leonard E Egede2.   

Abstract

Although outcome inequalities for non-Hispanic black (NHB) kidney transplant recipients are well documented, there is paucity in data assessing the impact of cardiovascular disease (CVD) risk factors on this disparity in kidney transplantation. This was a longitudinal study of a national cohort of veteran kidney recipients transplanted between January 2001 and December 2007. Data included baseline characteristics acquired through the United States Renal Data System linked to detailed clinical follow-up information acquired through the Veterans Affairs electronic health records. Analyses were conducted using sequential multivariable modeling (Cox regression), incorporating blocks of variables into iterative nested models; 3139 patients were included (2095 non-Hispanic whites [66.7%] and 1044 NHBs [33.3%]). NHBs had a higher prevalence of hypertension (100% versus 99%; P<0.01) and post-transplant diabetes mellitus (59% versus 53%; P<0.01) with reduced control of hypertension (blood pressure <140/90 60% versus 69%; P<0.01), diabetes mellitus (A1c <7%, 35% versus 47%; P<0.01), and low-density lipoprotein (<100 mg/dL, 55% versus 61%; P<0.01). Adherence to medications used to manage CVD risk was significantly lower in NHBs. In the fully adjusted models, the independent risk of graft loss in NHBs was substantially reduced (unadjusted hazard ratio, 2.00 versus adjusted hazard ratio, 1.49). CVD risk factors and control reduced the influence of NHB race by 9% to 18%. Similar trends were noted for mortality, and estimates were robust across in sensitivity analyses. These results demonstrate that NHB kidney transplant recipients have significantly higher rates of CVD risk factors and reduced CVD risk control. These issues are likely partly related to medication nonadherence and meaningfully contribute to racial disparities for graft outcomes.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cardiovascular disease; diabetes mellitus; graft survival; hypertension; prevalence

Mesh:

Year:  2016        PMID: 27402921      PMCID: PMC4982810          DOI: 10.1161/HYPERTENSIONAHA.116.07775

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  62 in total

1.  Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients.

Authors:  D O McDaniel; W H Barber; C Nguyan; S W Rhodes; W L May; L S McDaniel; P J S Vig; L L Jemeson; D E Butkus
Journal:  Transpl Immunol       Date:  2003 Jan-Mar       Impact factor: 1.708

2.  Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study.

Authors:  Myra A Carpenter; Matthew R Weir; Deborah B Adey; Andrew A House; Andrew G Bostom; John W Kusek
Journal:  Clin Transplant       Date:  2012-07-09       Impact factor: 2.863

3.  Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients.

Authors:  M A Chisholm-Burns; C A Spivey; R Rehfeld; M Zawaideh; D J Roe; R Gruessner
Journal:  Am J Transplant       Date:  2009-08-14       Impact factor: 8.086

4.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

5.  Influence of race on kidney transplant survival.

Authors:  G Opelz; M R Mickey; P I Terasaki
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

Review 6.  Diabetic renal disease in African Americans.

Authors:  Errol D Crook
Journal:  Am J Med Sci       Date:  2002-02       Impact factor: 2.378

7.  African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients.

Authors:  David J Taber; Mulugeta G Gebregziabher; Titte R Srinivas; Kenneth D Chavin; Prabhakar K Baliga; Leonard E Egede
Journal:  Pharmacotherapy       Date:  2015-05-23       Impact factor: 4.705

8.  The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry.

Authors:  M S Leffell; A G Steinberg; W B Bias; C H Machan; A A Zachary
Journal:  Transplantation       Date:  1994-11-27       Impact factor: 4.939

Review 9.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

10.  Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?

Authors:  Mukoso N Ozieh; David J Taber; Leonard E Egede
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more
  12 in total

1.  Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study.

Authors:  Sandra Aleksic; Ruth Eisenberg; Effie Tsomos; Sara Zahedpour Anaraki; Emily Japp; Laxmi Upadhyay; Wenzhu Bi Mowrey; Enver Akalin; Joel Zonszein
Journal:  Diabetes Res Clin Pract       Date:  2020-05-20       Impact factor: 5.602

Review 2.  Mortality Disparities in Racial/Ethnic Minority Groups in the Veterans Health Administration: An Evidence Review and Map.

Authors:  Kim Peterson; Johanna Anderson; Erin Boundy; Lauren Ferguson; Ellen McCleery; Kallie Waldrip
Journal:  Am J Public Health       Date:  2018-03       Impact factor: 9.308

3.  Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

Authors:  David J Taber; Zemin Su; James N Fleming; John W McGillicuddy; Maria A Posadas-Salas; Frank A Treiber; Derek Dubay; Titte R Srinivas; Patrick D Mauldin; William P Moran; Prabhakar K Baliga
Journal:  Transplantation       Date:  2017-12       Impact factor: 4.939

4.  The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.

Authors:  David J Taber; Zemin Su; James N Fleming; Nicole A Pilch; Thomas Morinelli; Patrick Mauldin; Derek Dubay
Journal:  Transpl Int       Date:  2018-09-16       Impact factor: 3.782

5.  Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.

Authors:  Courtenay M Holscher; Xun Luo; Allan B Massie; Tanjala S Purnell; Jacqueline M Garonzik Wang; Sunjae Bae; Macey L Henderson; Fawaz Al Ammary; Shane E Ottman; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-10-16       Impact factor: 8.086

6.  Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Aurora Posadas; Caitlin Schaffner; Leonard E Egede; Prabhakar K Baliga
Journal:  J Am Coll Clin Pharm       Date:  2018-06-21

7.  Concepts of Genomics in Kidney Transplantation.

Authors:  William S Oetting; Casey Dorr; Rory P Remmel; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Curr Transplant Rep       Date:  2017-05-24

8.  Posttransplant Medical Adherence: What Have We Learned and Can We Do Better?

Authors:  Mary Amanda Dew; Donna M Posluszny; Andrea F DiMartini; Larissa Myaskovsky; Jennifer L Steel; Annette J DeVito Dabbs
Journal:  Curr Transplant Rep       Date:  2018-04-17

9.  Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.

Authors:  Andrew J Cole; Reginald W Johnson; Leonard E Egede; Prabhakar K Baliga; David J Taber
Journal:  Contemp Clin Trials Commun       Date:  2017-11-23

10.  Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.

Authors:  David J Taber; Mulugeta Gebregziabher; Titte Srinivas; Leonard E Egede; Prabhakar K Baliga
Journal:  Ann Transplant       Date:  2018-02-16       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.